Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siyang Leng

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 26, 2019
One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosisCamille V Edwards, Divaya Bhutani, Markus Mapara, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2020
Timing of Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Current TherapiesSiyang Leng, Erin Moshier, Douglas Tremblay, et al.
Cancer Medicine|February 13, 2024
Real-world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemiaScott F Huntington, Enrico de Nigris, Justin T Puckett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 20, 2022
Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African MenKara I Cicero, Maureen Joffe, Moosa Patel, et al.
Future Oncology (London, England)|December 19, 2025
Real-world cardiac events and outcomes in cBTKi-treated chronic lymphocytic leukemia patientsDavid Dingli, Enrico De Nigris, Siyang Leng, et al.
Cancer Medicine|December 21, 2025
Healthcare Resource Utilization and Costs in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Treated With Covalent Bruton's Tyrosine Kinase Inhibitors: Real-World Impact of Cardiovascular Adverse EventsMavis Obeng-Kusi, Enrico De Nigris, Siyang Leng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 20, 2019
Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple MyelomaSiyang Leng, Yizhen Chen, Wei-Yann Tsai, et al.
Blood Neoplasia|June 23, 2025
Real-world characteristics, treatment patterns, and outcomes of patients with 2 or more LOTs for CLL/SLL in the United StatesMatthew S Davids, Jacob Ambrose, Enrico de Nigris, et al.
Leukemia & Lymphoma|May 2, 2024
Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal studyScott F Huntington, Wendy Y Cheng, Eric M Sarpong, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 26, 2019
One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosisCamille V Edwards, Divaya Bhutani, Markus Mapara, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2020
Timing of Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Current TherapiesSiyang Leng, Erin Moshier, Douglas Tremblay, et al.
Cancer Medicine|February 13, 2024
Real-world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemiaScott F Huntington, Enrico de Nigris, Justin T Puckett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 20, 2022
Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African MenKara I Cicero, Maureen Joffe, Moosa Patel, et al.
Future Oncology (London, England)|December 19, 2025
Real-world cardiac events and outcomes in cBTKi-treated chronic lymphocytic leukemia patientsDavid Dingli, Enrico De Nigris, Siyang Leng, et al.
Cancer Medicine|December 21, 2025
Healthcare Resource Utilization and Costs in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Treated With Covalent Bruton's Tyrosine Kinase Inhibitors: Real-World Impact of Cardiovascular Adverse EventsMavis Obeng-Kusi, Enrico De Nigris, Siyang Leng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 20, 2019
Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple MyelomaSiyang Leng, Yizhen Chen, Wei-Yann Tsai, et al.
Blood Neoplasia|June 23, 2025
Real-world characteristics, treatment patterns, and outcomes of patients with 2 or more LOTs for CLL/SLL in the United StatesMatthew S Davids, Jacob Ambrose, Enrico de Nigris, et al.
Leukemia & Lymphoma|May 2, 2024
Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal studyScott F Huntington, Wendy Y Cheng, Eric M Sarpong, et al.
Pageof 4